Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder

Sponsors

Lead Sponsor: HaEmek Medical Center, Israel

Source HaEmek Medical Center, Israel
Brief Summary

The use of corticosteroid subacromial injections have been found to be effective for the treatment of shoulder pain. Higher doses may be better than lower doses for subacromial corticosteroid injection for rotator cuff tendonitis. The investigators aim this study to compare 2 doses of corticosteroids.

Overall Status Withdrawn
Start Date June 2009
Completion Date April 2010
Primary Completion Date April 2010
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
constant score 9 month
Condition
Intervention

Intervention Type: Drug

Intervention Name: Betamethasone Sodium Phosphate

Description: 1cc:2cc

Other Name: diprospan

Intervention Type: Drug

Intervention Name: 1 cc - Betamethasone Sodium Phosphate

Description: Betamethasone Sodium Phosphate

Arm Group Label: 1 cc - Betamethasone Sodium Phosphate

Other Name: diprospan

Intervention Type: Drug

Intervention Name: 2 cc - Betamethasone Sodium Phosphate

Description: Betamethasone Sodium Phosphate

Arm Group Label: 2 cc - Betamethasone Sodium Phosphate

Other Name: diprospan

Eligibility

Criteria:

Inclusion Criteria: - subacromial bursitis - tendinitis - Calcific Tendonitis Exclusion Criteria: - rotator cuff tear - osteoarthritis - pregnancy - local or systemic infection - steroid or lidocaine sensitivity

Gender: All

Minimum Age: 35 Years

Maximum Age: N/A

Healthy Volunteers: No

Location
Facility: Haemek Medical Center
Location Countries

Israel

Verification Date

June 2015

Responsible Party

Name Title: orit semana

Organization: haemek medical center

Keywords
Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Label: 1 cc - Betamethasone Sodium Phosphate

Type: Active Comparator

Description: 1 cc - Betamethasone Sodium Phosphate

Label: 2 cc - Betamethasone Sodium Phosphate

Type: Active Comparator

Description: 2 cc - Betamethasone Sodium Phosphate

Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Primary Purpose: Treatment

Masking: None (Open Label)

Source: ClinicalTrials.gov